Amylyx Pharmaceuticals (AMLX)
Quick facts
| Ticker | AMLX (NASDAQ) |
|---|
Marketed products
- Relyvrio · Metabolic
Relyvrio works by inhibiting the enzyme phospholipase A2, which is involved in the breakdown of lipids in the brain.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: